Department of Clinical Neurosciences and Diagnostic Imaging (F.B., J.M.O., P.C., W.Q., N.S., K.Z., A.W., M.A.A., B.K.M., M.D.H., M.G.), University of Calgary, Canada.
Diagnostic and Interventional Neuroradiology Department, University Hospital of Tours, France (F.B.).
Stroke. 2023 Feb;54(2):448-456. doi: 10.1161/STROKEAHA.122.040542. Epub 2023 Jan 23.
Distal embolization (DE) is a common complication of endovascular treatment (EVT). We investigated the association of radiological thrombus characteristics and treatment details with DE.
Patients with thin-slice (≤2.5 mm) baseline noncontrast computed tomography and computed tomography angiography from the ESCAPE-NA1 trial (Efficacy and Safety of Nerinetide for the Treatment of Acute Ischemic Stroke) were included. Thrombus annotation was performed manually on coregistered scans by experienced readers. We assessed thrombus location, distance from internal carotid artery terminus, length, perviousness, absolute attenuation, and hyperdense artery sign. In addition, we evaluated balloon guide catheter use during EVT, first-line EVT approach, the number of thrombectomy passes, and prior intravenous thrombolysis administration. DE was defined as the occurrence of emboli distal to the target artery or in new territories during EVT. The association between thrombus characteristics, treatment details, and DE was evaluated using descriptive statistics and multivariable mixed-effects logistic regression, resulting in adjusted odds ratios (aOR) with 95% CI. Interaction between IVT and radiological thrombus characteristics was assessed by adding interaction terms in separate models.
In total, 496 out of 1105 (44.9%) ESCAPE-NA1 patients were included. DE was detected in 251 out of 496 patients (50.6%). Patients with DE had longer thrombi (median, 28.5 [interquartile range, 20.8-42.3] mm versus 24.4 [interquartile range, 17.1-32.4] mm; <0.01). There were no statistically significant differences in the other thrombus characteristics. Factors associated with DE were thrombus length (aOR, 1.02 [95% CI, 1.01-1.04]), balloon guide catheter use (aOR, 0.49 [95% CI, 0.29-0.85]), and number of passes (aOR, 1.24 [95% CI, 1.04-1.47]). In patients with hyperdense artery sign, IVT was associated with reduced odds of DE (aOR, 0.55 [95% CI, 0.31-0.97]), for interaction=0.04.
DE was associated with longer thrombi, no balloon guide catheter use, and more EVT passes. IVT was associated with a reduced risk of DE in patients with hyperdense artery sign. These findings may support treatment decisions on IVT and EVT approaches.
远端栓塞(DE)是血管内治疗(EVT)的常见并发症。我们研究了影像学血栓特征和治疗细节与 DE 的关系。
纳入 ESCAPE-NA1 试验(Nerinetide 治疗急性缺血性脑卒中的疗效和安全性)中基线非对比增强计算机断层扫描和计算机断层血管造影的薄层(≤2.5mm)患者。由有经验的读者在配准的扫描上手动进行血栓注释。我们评估了血栓的位置、距颈内动脉末端的距离、长度、通透度、绝对衰减和高密度动脉征。此外,我们评估了 EVT 期间使用球囊引导导管、一线 EVT 方法、取栓次数和静脉溶栓治疗的应用。DE 定义为 EVT 期间目标动脉远端或新部位出现栓塞。使用描述性统计和多变量混合效应逻辑回归评估血栓特征、治疗细节与 DE 之间的关系,得到调整后的优势比(aOR)和 95%置信区间(CI)。通过在单独的模型中添加交互项,评估 IVT 与影像学血栓特征之间的交互作用。
在 ESCAPE-NA1 试验的 1105 例患者中,共有 496 例(44.9%)患者入选。在 496 例患者中,有 251 例(50.6%)患者发生 DE。DE 患者的血栓长度更长(中位数,28.5[四分位距,20.8-42.3]mm 比 24.4[四分位距,17.1-32.4]mm;<0.01)。其他血栓特征无统计学差异。与 DE 相关的因素包括血栓长度(aOR,1.02[95%CI,1.01-1.04])、球囊引导导管使用(aOR,0.49[95%CI,0.29-0.85])和取栓次数(aOR,1.24[95%CI,1.04-1.47])。在高密度动脉征患者中,IVT 与 DE 发生率降低相关(aOR,0.55[95%CI,0.31-0.97]),交互作用检验=0.04。
DE 与血栓更长、不使用球囊引导导管和更多的 EVT 次数相关。在高密度动脉征患者中,IVT 与 DE 风险降低相关。这些发现可能为 IVT 和 EVT 方法的治疗决策提供支持。